Lifecore Biomedical Market Sentiment

Lifecore Biomedical Inc

LFCRNASDAQ

$6.59

0.071.07%

近くで: Sep 29, 5:00 PM EST

$6.58

-0.01-0.15%

時間外: 6:19 PM EST

PRO

なぜ動いているのか？:Lifecore Biomedical shares are trading higher after the company announced t...

M&A: Lifecore Biomedical (LFCR) announced it will be acquired by Webster Equity Partners on Monday, September 28, 2026 for $663.7M paid in cash

Market sentiment signals for Lifecore Biomedical (LFCR): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▼ 8.8% short float

Options Flow▼ 2.53 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

5 analysts

Options Flow (P/C)

2.53

More puts — Bearish

15 calls · 38 puts

Avg Consensus PT

+21.6%

Highest Price Target

$10

+52.0%

Craig-Hallum

Lowest Price Target

-8.8%

Stephens & Co.

Short Interest

8.8%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 29, 2026	Barrington Research	Michael Petusky—	—	—	Downgrade	Outperform→Market Perform
Sep 28, 2026	William Blair	Max Smock—	—	—	Downgrade	Outperform→Market Perform
Jun 16, 2026	Barrington Research	Michael Petusky—	-1.2%	$6 → $7	Maintained	Outperform
Apr 29, 2026	Barrington Research	Michael Petusky—	-8.8%	$6 → $6	Maintained	Outperform
Mar 27, 2026	Barrington Research	Michael Petusky—	-16.4%	$6 → $6	Maintained	Outperform
Mar 24, 2026	Barrington Research	Michael Petusky—	-16.4%	$6 → $6	Maintained	Outperform
Mar 17, 2026	Barrington Research	Michael Petusky—	-16.4%	$6	Upgrade	Market Perform→Outperform
Sep 4, 2025	Keybanc	Paul Knight—	—	—	Initiate	Sector Weight
May 21, 2025	William Blair	Max Smock—	—	—	Initiate	Outperform
Jan 3, 2025	Stephens & Co.	Jacob Johnson—	-8.8%	$6 → $6	Maintained	Equal-Weight
Nov 22, 2024	Craig-Hallum	Matthew Hewitt—	+52.0%	$8 → $10	Maintained	Buy
Oct 7, 2024	Stephens & Co.	Jacob Johnson—	-8.8%	$5 → $6	Maintained	Equal-Weight
Sep 5, 2024	Craig-Hallum	Matthew Hewitt—	+21.6%	$8	Initiate	Buy
Aug 28, 2024	Barrington Research	Michael Petusky—	—	—	Downgrade	Outperform→Market Perform